Kaname Yoshizawa
Department of Internal Medicine
Shinshu University School of Medicine
Matsumoto
Japan
[email]@hsp.md.shinshu-u.ac.jp
Name/email consistency: high
- De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis. Yoshizawa, K., Shirakawa, H., Ichijo, T., Umemura, T., Tanaka, E., Kiyosawa, K., Imagawa, E., Matsuda, K., Hidaka, E., Sano, K., Nakazawa, Y., Ikegami, T., Hashikura, Y., Miyagawa, S., Ota, M., Nakano, M. Clin. Transplant (2008)
- Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. Yoshizawa, K., Ota, M., Katsuyama, Y., Ichijo, T., Matsumoto, A., Tanaka, E., Kiyosawa, K. J. Hepatol. (2005)
- Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease. Yoshizawa, K., Ota, M., Saito, S., Maruyama, A., Yamaura, T., Rokuhara, A., Orii, K., Ichijo, T., Matsumoto, A., Tanaka, E., Kiyosawa, K. Tissue. Antigens (2003)
- Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines. Yoshizawa, K., Cioca, D.P., Kawa, S., Tanaka, E., Kiyosawa, K. Cancer (2002)